Oncimmune receives regulatory approval from Israel for lung cancer diagnosis kit

Lung cancer kills more people in Israel than any other form of the disease, said the company.

More From BioPortfolio on "Oncimmune receives regulatory approval from Israel for lung cancer diagnosis kit"